rs147346173
Positions:
Variant summary
Our verdict is Uncertain significance. Variant got 3 ACMG points: 3P and 0B. PM2PP3
The NM_006208.3(ENPP1):āc.2330A>Gā(p.His777Arg) variant causes a missense change. The variant allele was found at a frequency of 0.000241 in 1,614,142 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ā ).
Frequency
Genomes: š 0.00026 ( 0 hom., cov: 33)
Exomes š: 0.00024 ( 0 hom. )
Consequence
ENPP1
NM_006208.3 missense
NM_006208.3 missense
Scores
7
8
4
Clinical Significance
Conservation
PhyloP100: 5.70
Genes affected
ENPP1 (HGNC:3356): (ectonucleotide pyrophosphatase/phosphodiesterase 1) This gene is a member of the ecto-nucleotide pyrophosphatase/phosphodiesterase (ENPP) family. The encoded protein is a type II transmembrane glycoprotein comprising two identical disulfide-bonded subunits. This protein has broad specificity and cleaves a variety of substrates, including phosphodiester bonds of nucleotides and nucleotide sugars and pyrophosphate bonds of nucleotides and nucleotide sugars. This protein may function to hydrolyze nucleoside 5' triphosphates to their corresponding monophosphates and may also hydrolyze diadenosine polyphosphates. Mutations in this gene have been associated with 'idiopathic' infantile arterial calcification, ossification of the posterior longitudinal ligament of the spine (OPLL), and insulin resistance. [provided by RefSeq, Jul 2008]
Genome browser will be placed here
ACMG classification
Classification made for transcript
Verdict is Uncertain_significance. Variant got 3 ACMG points.
PM2
Very rare variant in population databases, with high coverage;
PP3
MetaRNN computational evidence supports a deleterious effect, 0.775
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
ENPP1 | NM_006208.3 | c.2330A>G | p.His777Arg | missense_variant | 23/25 | ENST00000647893.1 | NP_006199.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
ENPP1 | ENST00000647893.1 | c.2330A>G | p.His777Arg | missense_variant | 23/25 | NM_006208.3 | ENSP00000498074.1 | |||
ENPP1 | ENST00000513998.5 | n.*1167A>G | non_coding_transcript_exon_variant | 23/25 | 5 | ENSP00000422424.1 | ||||
ENPP1 | ENST00000684674.1 | n.761A>G | non_coding_transcript_exon_variant | 4/6 | ||||||
ENPP1 | ENST00000513998.5 | n.*1167A>G | 3_prime_UTR_variant | 23/25 | 5 | ENSP00000422424.1 |
Frequencies
GnomAD3 genomes AF: 0.000263 AC: 40AN: 152198Hom.: 0 Cov.: 33
GnomAD3 genomes
AF:
AC:
40
AN:
152198
Hom.:
Cov.:
33
Gnomad AFR
AF:
Gnomad AMI
AF:
Gnomad AMR
AF:
Gnomad ASJ
AF:
Gnomad EAS
AF:
Gnomad SAS
AF:
Gnomad FIN
AF:
Gnomad MID
AF:
Gnomad NFE
AF:
Gnomad OTH
AF:
GnomAD3 exomes AF: 0.000119 AC: 30AN: 251424Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135888
GnomAD3 exomes
AF:
AC:
30
AN:
251424
Hom.:
AF XY:
AC XY:
12
AN XY:
135888
Gnomad AFR exome
AF:
Gnomad AMR exome
AF:
Gnomad ASJ exome
AF:
Gnomad EAS exome
AF:
Gnomad SAS exome
AF:
Gnomad FIN exome
AF:
Gnomad NFE exome
AF:
Gnomad OTH exome
AF:
GnomAD4 exome AF: 0.000239 AC: 349AN: 1461826Hom.: 0 Cov.: 32 AF XY: 0.000217 AC XY: 158AN XY: 727212
GnomAD4 exome
AF:
AC:
349
AN:
1461826
Hom.:
Cov.:
32
AF XY:
AC XY:
158
AN XY:
727212
Gnomad4 AFR exome
AF:
Gnomad4 AMR exome
AF:
Gnomad4 ASJ exome
AF:
Gnomad4 EAS exome
AF:
Gnomad4 SAS exome
AF:
Gnomad4 FIN exome
AF:
Gnomad4 NFE exome
AF:
Gnomad4 OTH exome
AF:
GnomAD4 genome AF: 0.000263 AC: 40AN: 152316Hom.: 0 Cov.: 33 AF XY: 0.000215 AC XY: 16AN XY: 74472
GnomAD4 genome
AF:
AC:
40
AN:
152316
Hom.:
Cov.:
33
AF XY:
AC XY:
16
AN XY:
74472
Gnomad4 AFR
AF:
Gnomad4 AMR
AF:
Gnomad4 ASJ
AF:
Gnomad4 EAS
AF:
Gnomad4 SAS
AF:
Gnomad4 FIN
AF:
Gnomad4 NFE
AF:
Gnomad4 OTH
AF:
Alfa
AF:
Hom.:
Bravo
AF:
TwinsUK
AF:
AC:
0
ALSPAC
AF:
AC:
1
ESP6500AA
AF:
AC:
0
ESP6500EA
AF:
AC:
6
ExAC
AF:
AC:
16
EpiCase
AF:
EpiControl
AF:
ClinVar
Significance: Uncertain significance
Submissions summary: Uncertain:5
Revision: criteria provided, multiple submitters, no conflicts
LINK: link
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Women's Health and Genetics/Laboratory Corporation of America, LabCorp | Oct 04, 2023 | Variant summary: ENPP1 c.2330A>G (p.His777Arg) results in a non-conservative amino acid change located in the DNA/RNA non-specific endonuclease domain (IPR001604) of the encoded protein sequence. Four of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00012 in 251424 control chromosomes (gnomAD). c.2330A>G has been reported in the literature in a homozygous individual affected with generalized arterial calcification of infancy (Rutsch_ 2008) and a compound heterozygous (Ferreira_ 2021) GACI survivor. However, the homozygous case was reported with a splice site variant in cis in one of the alleles, suggesting that this variant may be causal only when combined with a null variant. It has also been reported in heterozygous state in two individuals affected with early onset osteoporosis (Oheim_2020) and ectopic mineralization (Saeidian_2022). At least one publication reports experimental evidence evaluating an impact on protein function. The most pronounced variant effect results in 30%-50% of normal activity (Stella_ 2016). The following publications have been ascertained in the context of this evaluation (PMID: 33005041, 35276006, 20016754, 34906475, 27467858). Three submitters have cited clinical-significance assessments for this variant to ClinVar after 2014. All submitters classified the variant as uncertain significance. Based on the evidence outlined above, the variant was classified as VUS-possibly pathogenic. - |
Inborn genetic diseases Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | May 03, 2024 | The c.2330A>G (p.H777R) alteration is located in exon 23 (coding exon 23) of the ENPP1 gene. This alteration results from a A to G substitution at nucleotide position 2330, causing the histidine (H) at amino acid position 777 to be replaced by an arginine (R). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Arterial calcification, generalized, of infancy, 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Baylor Genetics | Sep 01, 2017 | This mutation has been previously reported as disease-causing and was found once in our laboratory in trans with another missense variant in a 1-year-old male with fibromuscular dysplasia, coarctation, low sodium level, cardiomyopathy, hypertension, seizures - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | May 23, 2023 | In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. Experimental studies have shown that this missense change affects ENPP1 function (PMID: 27467858, 31805212). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt ENPP1 protein function. ClinVar contains an entry for this variant (Variation ID: 561005). This missense change has been observed in individual(s) with clinical features of ENPP1-related conditions (PMID: 20016754, 31805212, 33005041, 34906475). This variant is present in population databases (rs147346173, gnomAD 0.03%). This sequence change replaces histidine, which is basic and polar, with arginine, which is basic and polar, at codon 777 of the ENPP1 protein (p.His777Arg). - |
Type 2 diabetes mellitus;C0028754:Obesity;C2750078:Hypophosphatemic rickets, autosomal recessive, 2;C3809781:Hypopigmentation-punctate palmoplantar keratoderma syndrome;C4551985:Arterial calcification, generalized, of infancy, 1 Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Fulgent Genetics, Fulgent Genetics | May 05, 2022 | - - |
Computational scores
Source:
Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
BayesDel_addAF
Uncertain
T
BayesDel_noAF
Pathogenic
CADD
Uncertain
DANN
Uncertain
DEOGEN2
Uncertain
D;D
Eigen
Pathogenic
Eigen_PC
Pathogenic
FATHMM_MKL
Pathogenic
D
LIST_S2
Uncertain
.;D
M_CAP
Benign
D
MetaRNN
Pathogenic
D;D
MetaSVM
Uncertain
T
MutationAssessor
Pathogenic
M;M
PrimateAI
Uncertain
T
PROVEAN
Pathogenic
D;.
REVEL
Uncertain
Sift
Uncertain
D;.
Sift4G
Benign
T;.
Polyphen
D;D
Vest4
MVP
MPC
ClinPred
D
GERP RS
RBP_binding_hub_radar
RBP_regulation_power_radar
Varity_R
gMVP
Splicing
Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
Details are displayed if max score is > 0.2
Find out detailed SpliceAI scores and Pangolin per-transcript scores at